Impetigo is a common contagious skin infection. Bacteria like Staphylococcus aureus or Streptococcus pyogenes infect the outer layers of the skin. It mainly affects infants & young children. It usually appears as reddish sores on the face, arms, and legs. Glowderma introduced a novel non-fluorinated topical quinolone, Ozenoxacin 1% w/w which was approved by the USFDA for the treatment of Impetigo.